Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 09, 2016 02:30 ET | Source: Diamyd Medical AB (publ)

Diamyd Medical expands activities to both type 1 and type 2 diabetes as well as rheumatoid arthritis with proprietary GABA drug

Diamyd Medical (Nasdaq Stockholm First North, Ticker: DMYD B) today announced that the Company will expand its activities to include both type 1 and type 2 diabetes as well as rheumatoid arthritis,...
September 09, 2016 02:30 ET | Source: Diamyd Medical AB (publ)

Diamyd Medical breddar verksamheten mot både typ 1- och typ 2-diabetes samt reumatoid artrit med eget GABA-läkemedel

Diamyd Medical (Nasdaq Stockholm First North, DMYD B) meddelar idag att Bolaget breddar verksamheten till att omfatta både typ 1- och typ 2-diabetes samt reumatoid artrit, vilken planeras drivas genom...
September 07, 2016 06:30 ET | Source: Diamyd Medical AB (publ)

Diamyd Medical provides update on clinical studies with Diamyd®

Diamyd Medical (Nasdaq First North, Stockholm, DMYD B) participates in six clinical studies with the diabetes vaccine Diamyd® for the treatment and prevention of type 1 diabetes. The Company announced...
September 07, 2016 06:30 ET | Source: Diamyd Medical AB (publ)

Diamyd Medical ger uppdatering om kliniska studier med Diamyd®

Diamyd Medical (Nasdaq Stockholm First North, DMYD B) deltar i sex kliniska studier med diabetesvaccinet Diamyd® för behandling och prevention av typ 1 -diabetes. Bolaget meddelar idag att ytterligare...
September 01, 2016 02:30 ET | Source: Diamyd Medical AB (publ)

Diamyd Medical appoints new head of Clinical Development

Diamyd Medical (Nasdaq Stockholm First North, Ticker: DMYD B) today announced that Martina Widman, M.Sc. in Mechanical Engineering from the Royal Institute of Technology in Stockholm and employed in...
September 01, 2016 02:30 ET | Source: Diamyd Medical AB (publ)

Diamyd Medical får ny chef för klinisk utveckling

Diamyd Medical (Nasdaq Stockholm First North, DMYD B) meddelar idag att Martina Widman, civilingenjör från KTH och anställd i Diamyd Medical sedan 2008, per den 1 september efterträder Erika Hillborg...
August 02, 2016 02:30 ET | Source: Diamyd Medical AB (publ)

Diamyd Medical’s associated company Cellaviva is appointed European distributor for StemBioSys

Diamyd Medical (Nasdaq Stockholm First North, Ticker: DMYD B) today announced that its associated company Cellaviva AB has signed an agreement regarding the European distribution rights for a stem...
August 02, 2016 02:30 ET | Source: Diamyd Medical AB (publ)

Diamyd Medicals intressebolag Cellaviva utses till europeisk återförsäljare för StemBioSys

Diamyd Medical (Nasdaq Stockholm First North, Ticker: DMYD B) meddelade idag att Diamyd Medicals intressebolag Cellaviva AB skrivit avtal om europeiska återförsäljningsrättigheter för en...
July 29, 2016 04:39 ET | Source: Diamyd Medical AB (publ)

Diamyd Medical tecknar avtal med Janssen R&D, JDRF och University of Alabama om pågående GABA/GAD-studie

Diamyd Medical (Nasdaq Stockholm First North, DMYD B) meddelar idag att Diamyd Medical har tecknat ett avtal med Janssen Research & Development, Juvenile Diabetes Research Foundation (JDRF) och...
July 29, 2016 04:39 ET | Source: Diamyd Medical AB (publ)

Diamyd Medical signs agreement with Janssen R&D, JDRF and UAB regarding ongoing GABA/GAD-trial

Diamyd Medical (Nasdaq Stockholm First North, Ticker: DMYD B) today announced that it has signed an agreement with Janssen Research & Development, the Juvenile Diabetes Research Foundation (JDRF) and...